Demographics and Clinical Characteristics of Patients With Opioid Use Disorder and Offered Medication-Assisted Treatment in the Emergency Department

被引:0
|
作者
Fu, Wayne [1 ,2 ]
Adzhiashvili, Victoria [3 ]
Majlesi, Nima [4 ]
机构
[1] Mercy Hosp, Emergency Med, Buffalo, NY 14220 USA
[2] Staten Isl Univ Hosp, Emergency Med, Staten Isl, NY 10305 USA
[3] Staten Isl Univ Hosp, Psychiat, Staten Isl, NY USA
[4] Staten Isl Univ Hosp, Med Toxicol, Staten Isl, NY USA
关键词
buprenorphine; substance abuse; drug addiction; medication for opioid use disorder; opioid use disorders; BUPRENORPHINE;
D O I
10.7759/cureus.41464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective The opioid use disorder (OUD) epidemic is a persistent public health crisis in the United States. Medication -assisted treatment (MAT) with opioid agonists, including buprenorphine, is an effective treatment and is commonly initiated in the emergency department (ED). This study describes the demographics and clinical characteristics of OUD patients presenting to the ED and evaluated for MAT. Methodology A retrospective, single-center descriptive study of 129 adult patients presenting to the ED between July 2018 and July 2020 with OUD and evaluated for MAT. Results A total of 129 patients were assessed for MAT. About half (53%) received MAT; the remaining received only a referral (35%) or declined any intervention (12%). The median age was 36 years interquartile range (IQR, 28-46 years) and predominantly male (73%), single (65%), white (73%), unemployed (57%) with public insurance (55%), and without a primary care physician (58%). Majority of the patients presented with opioid withdrawal (62%) or intoxication (15%), while 23% presented with other complaints. About half of the patients (51%) were discharged with a naloxone kit. The majority of the patients were induced with buprenorphine with 4 mg or less (54%) and only 6% of patients received repeat dosing. Conclusions Male, white patients who are unmarried and unemployed, lack primary care follow-up, and rely on public insurance are more likely to be candidates for MAT. Providers should always maintain a high suspicion of opioid misuse and optimize treatment for those in withdrawal. Understanding these characteristics in conjunction with recent health policy changes will hopefully guide and encourage ED-initiated interventions in combating the opioid crisis.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Trends in receipt of medication-assisted treatment for pregnant women with opioid use disorder in the United States
    MacAfee, Lauren
    Sawyer, Anne
    Terplan, Mishka
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E125 - E125
  • [42] Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
    van Reekum, Emma A.
    Rosic, Tea
    Hudson, Jacqueline
    Sanger, Nitika
    Marsh, David C.
    Worster, Andrew
    Thabane, Lehana
    Samaan, Zainab
    BIOLOGY OF SEX DIFFERENCES, 2020, 11 (01)
  • [43] Personal and Socioeconomic Determinants in Medication-assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults
    Grubb, Laura K.
    CLINICAL THERAPEUTICS, 2019, 41 (09) : 1669 - 1680
  • [44] Elective Naloxone-Induced Opioid Withdrawal for Rapid Initiation of Medication-Assisted Treatment of Opioid Use Disorder
    Phillips, Reid H.
    Salzman, Matthew
    Haroz, Rachel
    Rafeq, Rachel
    Mazzarelli, Anthony J.
    Pelletier-Bui, Alexis
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (03) : 430 - 432
  • [45] ALCOHOL AND ILLICIT SUBSTANCE USE IMPACT TREATMENT OUTCOMES AMONG PATIENTS RECEIVING OUTPATIENT MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER
    Van Dyke, N.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 134A - 134A
  • [46] A Mobile Health App to Support Patients Receiving Medication-Assisted Treatment for Opioid Use Disorder: Development and Feasibility Study
    Waselewski, Marika Elise
    Flickinger, Tabor Elisabeth
    Canan, Chelsea
    Harrington, William
    Franklin, Taylor
    Otero, Kori Nicole
    Huynh, Jacqueline
    Waldman, Ava Lena Davila
    Hilgart, Michelle
    Ingersoll, Karen
    Tiouririne, Nassima Ait-Daoud
    Dillingham, Rebecca Anne
    JMIR FORMATIVE RESEARCH, 2021, 5 (02)
  • [47] Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol
    Sanger, Nitika
    Shahid, Hamnah
    Dennis, Brittany B.
    Hudson, Jackie
    Marsh, David
    Sanger, Stephanie
    Worster, Andrew
    Teed, Rand
    Rieb, Launette
    Tugwell, Peter
    Hutton, Brian
    Shea, Beverley
    Beaton, Dorcas
    Corace, Kimberly
    Rice, Danielle
    Maxwell, Lara
    Samaan, M. Constantine
    de Souza, Russell J.
    Thabane, Lehana
    Samaan, Zainab
    BMJ OPEN, 2018, 8 (12):
  • [48] INDIVIDUALS RECEIVING METHADONE FOR MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER SHOW EVIDENCE OF RESPIRATORY DEPRESSION
    Finlay, M.
    Wilson, M.
    Erwin, J. A.
    Hansen, D. A.
    Layton, M. E.
    Quock, R. M.
    Van Dongen, H.
    SLEEP, 2020, 43 : A278 - A278
  • [49] Medication-assisted therapies for opioid use disorders in patients with chronic pain
    Oesterle, Tyler S.
    Kolla, Bhanu Prakash
    Rummans, Teresa A.
    Gold, Mark S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 411
  • [50] Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program
    Kaucher, Kevin A.
    Caruso, Emily H.
    Sungar, Gannon
    Gawenus, Lisa
    Hurlbut, Katherine
    Sanchez, Dayan Colon
    Broderick, Kerry
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (02): : 300 - 304